Mineralocorticoid receptor antagonists showed short-term subretinal fluid reduction in cCSCR but lacked sustained long-term ...

Metformin, as an insulin sensitizer, combined with spironolactone, an antiandrogen medication, may exert complementary effects on PCOS. We therefore performed a meta-analysis of trials in which ...

Medically reviewed by Peter Weiss, MD Some women have testosterone levels that are higher than normal, often due to polycystic ovary syndrome (PCOS), ovarian cancer, glandular disorders, or unknown ...

Spironolactone does not reduce the rate of cardiovascular death or heart failure in patients undergoing maintenance dialysis.

During a session at the Heart in Diabetes CME Conference, speakers highlighted four papers recently published in Circulation ...

Daily treatment with a mineralocorticoid receptor antagonist flopped for reducing serious cardiac events in kidney failure patients on maintenance dialysis, a randomized trial found. Among over 2,500 ...